Thailand confirmed 470 mpox infections and three deaths between January 1 and October 31, 2026, according to figures released by the country's Department of Disease Control and reported by The Star. The department's director-general, Montien Kanasawadse, presented the tally on November 3 and called for anyone with suspicious symptoms to see a doctor quickly rather than wait.
The agency said early diagnosis and sustained monitoring remain central to containing the virus, and it urged people to seek care as soon as they notice anything unusual.
Why it matters
Mpox is still classified as a communicable disease under Thailand's Communicable Diseases Act 2015 and appears on the Ministry of Public Health's 2022 list of conditions requiring surveillance. That legal status means cases are tracked rather than treated as isolated incidents, and it gives health authorities a formal basis for monitoring and response.
The department also noted that transmission continues to be a concern in multiple parts of the world, so Thailand's domestic numbers sit within a wider international picture rather than a closed one.
Global figures cover a different window
Thai officials pointed to international data drawn from a World Health Organization report dated September 14. That report counted 68,096 confirmed infections and 272 deaths across 107 countries between January 1, 2025 and August 31.
The department was careful to stress that the global numbers span a different period from Thailand's 2026 statistics and should not be read as a direct comparison. The Star reports that the figures were cited to give context on the virus's continued circulation worldwide.
Symptoms can vary and do not always follow one pattern
Montien explained that anyone exposed to the virus can become infected, which makes familiarity with the warning signs important. Early illness often includes fever, headache, back pain, muscle aches and enlarged lymph nodes.
Skin changes may follow, appearing on the face, torso, genital area or around the anus. Some patients develop only a small number of lesions; others report pain in the anal region. Spots typically start as raised red bumps, then fill with fluid, later turn to pus and finally scab over. Crusting often begins at the centre of a lesion, and the spots tend to sit apart from one another rather than merge.
The department cautioned that the sequence is not fixed and that patients may not show every recognised sign. Its advice is to get medical advice for any unexplained rash, blister or sore, especially after a possible exposure, without waiting for lesions to spread.
Embarrassment is a barrier the department wants removed
Because lesions can appear on intimate parts of the body, some people hesitate to be examined. Montien addressed that directly, saying illness should not carry shame and encouraging patients to speak openly with clinicians about symptoms and any exposure history.
He said health workers are expected to respond with understanding, protect patient privacy and keep information confidential.
A rash alone cannot confirm mpox
The department emphasised that mpox cannot be diagnosed by looking at a rash or a photograph. Its appearance can overlap with herpes, chickenpox and other skin conditions, so clinical judgement and laboratory work are both required.
Doctors weigh symptoms and exposure history alongside test results. The main confirmatory tool is a polymerase chain reaction test, which looks for the virus's genetic material in samples taken from skin lesions.
Patients whose first assessment is unclear, or whose tests come back negative while symptoms persist, are advised to return if new lesions appear or their condition shifts. They should also tell doctors about earlier tests and any treatment received, so repeat sampling or further examination can be considered where appropriate.
Most recover with supportive care
Direk Khampaen, the department's deputy director-general, said the majority of patients recover without needing specialised treatment. Care generally centres on easing symptoms, controlling pain, guarding skin lesions against secondary infection and lowering the chance of complications.
He noted that people with weakened immune systems, pregnant women and young children face a higher risk of severe illness and need closer medical review. Whether a patient requires extra treatment or hospital admission is decided case by case.
The department listed warning signs that warrant immediate care: severe pain, trouble eating or drinking, lesions affecting the eyes, or symptoms that get worse.
What to watch: whether Thailand's case count stabilises through the final months of 2026, and whether the department adjusts its surveillance or public guidance in response.
